Home / Drug shortages / Dapsone Gel

Dapsone Gel — FDA Drug Shortage

To Be Discontinued — Amneal Pharmaceuticals

The FDA lists a drug shortage record for Dapsone Gel (gel) from Amneal Pharmaceuticals with status To Be Discontinued. The shortage was first posted on 03/27/2026.

Shortage Details

Status
To Be Discontinued
Company
Amneal Pharmaceuticals
Package NDC
69238-1627-6
Dosage Form
Gel
Presentation
Dapsone, Gel, 7.5% (NDC 69238-1627-6)
Initial Posting
03/27/2026
Revised Date

FDA data resources